Curated by THEOUTPOST
On Wed, 17 Jul, 4:04 PM UTC
2 Sources
[1]
Tempus to Report Second Quarter 2024 Financial Results on August 6
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the second quarter on Tuesday, August 6, 2024. The company will hold the second quarter 2024 earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
[2]
Tempus to Report Second Quarter 2024 Financial Results on August 6 By Investing.com
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the second quarter on Tuesday, August 6, 2024. The company will hold the second quarter 2024 earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers (NYSE:ROG). The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Share
Share
Copy Link
Tempus AI Inc., a leading AI-driven precision medicine company, has announced that it will release its second quarter 2024 financial results on August 6, 2023. The company will also host a conference call to discuss the results and provide a business update.
Tempus AI Inc., a prominent artificial intelligence-driven precision medicine company, has announced its plans to release the financial results for the second quarter of 2024 on Sunday, August 6, 2023 12. This announcement has caught the attention of investors and industry analysts alike, as it provides an opportunity to gauge the company's performance and future prospects.
In conjunction with the release of the financial results, Tempus will be hosting a conference call and live audio webcast 1. The call is scheduled to take place on Monday, August 7, 2023, at 8:00 a.m. Eastern Time (ET) 2. This timing allows investors and interested parties to review the results before the market opens, potentially influencing trading decisions for the day.
For those interested in participating in the conference call, Tempus has provided multiple ways to access the event:
These options ensure that both domestic and international participants can easily join the call and stay informed about the company's performance.
For those who prefer a visual component or cannot join via phone, Tempus will also be providing a live audio webcast of the conference call 1. The webcast will be accessible through the company's investor relations website at investors.tempus.com, under the "Events and Presentations" section 2.
Understanding that not all interested parties may be able to join the live call, Tempus has arranged for a replay of the conference call to be available. The replay can be accessed by calling 1-844-512-2921 (US) or 1-412-317-6671 (International) and using the replay pin number 13739753 12. This replay will be available until August 14, 2023, at 11:59 p.m. ET, giving ample time for review.
This announcement is significant for several reasons:
As the date approaches, market watchers will be keen to see how Tempus AI Inc. has performed in the second quarter and what this might indicate about the broader AI and healthcare technology sectors.
Reference
[1]
Tempus AI, Inc. (NASDAQ:TEM) released its Q4 2024 financial results, demonstrating significant progress in AI-powered healthcare solutions. The earnings call highlighted the company's achievements and future strategies.
2 Sources
2 Sources
Tempus AI's stock reaches an all-time high following a collaboration announcement with the Institute for Follicular Lymphoma Innovation. The company's AI-driven approach to precision medicine attracts significant investments from major funds.
4 Sources
4 Sources
Tempus AI, an AI-driven healthcare company, sees its stock price surge 108% in 2025 despite mixed Q4 earnings. The company's future looks promising but faces challenges in profitability and market expectations.
8 Sources
8 Sources
Multiple Tempus AI executives sell shares for tax purposes as the company makes strategic moves in genomics and AI-driven healthcare, receives FDA clearance for a new device, and faces analyst scrutiny.
6 Sources
6 Sources
Tempus AI, Inc. announces the clinical launch of its Immune Profile Score (IPS) algorithmic test and the acceptance of nine abstracts for presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting, showcasing advancements in AI-driven precision medicine for cancer treatment.
3 Sources
3 Sources
The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.
© 2025 TheOutpost.AI All rights reserved